(Q33775851)

29 July 2017

1 reference

title

Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines (English)

1 reference

29 July 2017

1 reference

Carter HB

1

1 reference

29 July 2017

Pearson JD

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

54

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

780-786

1 reference

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Prostate cancer screening: what we know and what we need to know.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Prostate cancer: are we screening and treating too much?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

The role of cervical cytology in the declining morbidity and mortality of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Cancer incidence and mortality, 1973-1995: a report card for the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Screening digital rectal examination and prostate cancer mortality: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Optimising the age, number of tests, and test interval for cervical screening in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Screening for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy--a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900271-X

7 January 2021

10.1016/S0090-4295(99)00271-X

Identifiers

DOI

1 reference

29 July 2017

1 reference